(NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced results from the first quarter 2024 and business highlights. “We are pleased to present another quarter of strong ...
Since 2016, the TrustRadius Top Rated Awards have become the B2B’s industry standard for unbiased recognition of excellent ...